Healthtech firm launches world’s first consumer epigenetic testing kit with £1.12m investment

Jan 10, 2019 · bdaily.co.uk

Fy38mvej06qkq0hcuv3qjjszmcp5tentqhuzlfaj

Healthtech company Chronomics has raised seven-figure seed funding and launched the world’s first consumer epigenetic testing kit.

The company has secured over £1.12m funding to date, including significant investment from venture capital firm Anthemis and follow-on backing from SOSV.

Other investors in Chronomics include angel Laurence Garrett, senior partner at Highland Europe.

Chronomics is seeking to revolutionise attitudes towards health management. It offers an epigenetic saliva test that profiles specific lifestyle and environmental indicators and provides accurate insights into an individual’s health, including their biological age and metabolic status.

Read Complete Article

RT @UKBAngels: As the 8th @MayorofLondon #TechInvest comes to a close we want to thank our incredible community partners for all their supp…

An honour to join @MikeBloomberg to welcome European Mayors to London ahead of the 8th EU Capital City Mayors Meeti… https://t.co/H75F5f73t9

"The #FutureofWork is coming, in some cases it's already here." The 2019 Future of Work Summit was one of the highl… https://t.co/7QGtZmsUPR

💞 🚀 Angelic! How about Creative Developer with @FoundersFactory? https://t.co/PewkIe3Wme #hiring #product

Huawei ramps up its technological Cold War propaganda https://t.co/HwAhAA6RlI

More in London